drugset
Drugs / COVAX
last change Dec 2021 re-read 2 minutes ago

COVAX

Vaccine

Developed for
pneumonia
Investigated by
Changchun Institute of Biological Products Co., Ltd. · Chengdu Institute of Biological Products Co.,Ltd. · China National Biotec Group Company Limited · Guangdong Center for Disease Prevention and Control · Henan Center for Disease Control and Prevention · Hubei Provincial Center for Disease Control and Prevention
+1 more · Wuhan Institute of Biological Products Co., Ltd

Trials 1 · a red edge is where a trial was stopped

today NCT05079152 · Ph 4
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05079152 May 2021 influenza, streptococcal pneumonia China National Biotec Group Company Limited Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as COVAX ClinicalTrials.gov intervention name — accepted as the source's own label NCT05079152 ↗
Modality Vaccine “Inactivated SARS-CoV-2 Vaccines (Vero Cell) (COVAX)” NCT05079152 ↗